Original article
English
el Mangoush M, Singh MK, Kumar S, Korajkio M, Gamati A.
Medicine Dpt., Hawari Hospital, Arab Medical University, Benghazi, Libya.
Bone Marrow Transplant. 1989 Dec;4 Suppl 3:100.
Abstract
Myelodysplastic syndromes (MDS) are a group of disorders characterised by progressive cytopenias and impaired maturation of haematopoietic cells. It carries a high mortality due to severe infections and/or bleeding, and transformation into acute myeloid leukaemia (AML). Its treatment is largely unsatisfactory except a few favorable reports with low-dose cytarabine therapy, which has recently created a widespread enthusiasm for its use.
Keywords: Evaluation of low-dose cytarabine therapy in myelodysplastic syndromes.
Link/DOI: